HPV jabs cut risk of dying from cervical cancer before 30 to almost zero

The study highlights that HPV vaccinations administered during early adolescence have nearly eliminated the risk of dying from cervical cancer before age 30, marking a significant medical breakthrough. However, there's a looming concern as vaccination rates have declined, potentially leading to a resurgence in cervical cancer cases and deaths. This underscores the importance of maintaining high vaccination rates to protect future generations from this deadly disease, emphasizing the need for public health initiatives to boost HPV vaccine uptake.